Pages that link to "Q37390663"

The following pages link to Estimating the public health impact of the effect of herpes simplex virus suppressive therapy on plasma HIV-1 viral load (Q37390663):

Displaying 12 items.

• The Sordid Affair Between Human Herpesvirus and HIV (Q28083192) (← links)
• Effects of valacyclovir on markers of disease progression in postpartum women co-infected with HIV-1 and herpes simplex virus-2 (Q28728582) (← links)
• Estimating the impact of plasma HIV-1 RNA reductions on heterosexual HIV-1 transmission risk (Q33697958) (← links)
• Autonomous targeting of infectious superspreaders using engineered transmissible therapies (Q33868991) (← links)
• Daily acyclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial (Q33881449) (← links)
• Modelling sexual transmission of HIV: testing the assumptions, validating the predictions (Q34071168) (← links)
• Can herpes simplex virus type 2 suppression slow HIV disease progression: a study protocol for the VALacyclovir In Delaying Antiretroviral Treatment Entry (VALIDATE) trial (Q34408313) (← links)
• The potential impact of RV144-like vaccines in rural South Africa: a study using the STDSIM microsimulation model (Q35169355) (← links)
• Time to Refocus on HSV Interventions for HIV Prevention? (Q35532849) (← links)
• Species-specific treatment effects of helminth/HIV-1 co-infection: a systematic review and meta-analysis (Q36069352) (← links)
• Modelling the interactions between herpes simplex virus type 2 and HIV: implications for the HIV epidemic in southern India (Q37575589) (← links)
• How universal does universal test and treat have to be? (Q89727365) (← links)